Celiac disease serology showed elevated anti-tTG2 IgA levels (103 ± 168 U/ml); about 37% of patients had a level more than 100 U/ml and anti-EMA IgA positivity in 51.85% (28/54) of patients. This evidence concerns the gene CD79A and celiac disease.